Latest stories on ANRO
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Alto Neuroscience promotes Nick Smith to president & CFO
Seeking Alpha50 · neutralgeneral
Alto Neuroscience Promotes Smith to President, CFO
TipRanks55 · neutralgeneral
Alto Neuroscience, Inc. (ANRO) files 8-K
SEC 8-K50 · neutralgeneral
Alto Neuroscience names Nick Smith president, CFO
The Fly55 · neutralgeneral
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
StockTitan55 · neutralgeneral
Alto Neuroscience price target raised to $55 from $50 at H.C. Wainwright
The Fly61 · neutralanalyst
Alto Neuroscience reports Q EPS (65c), consensus (77c)
The Fly34 · bearishearnings
Alto Neuroscience price target raised to $37 from $33 at BofA
The Fly61 · neutralanalyst
Alto Neuroscience GAAP EPS of -$0.65 beats by $0.08
Seeking Alpha56 · neutralearnings
Alto Neuroscience, Inc. (ANRO) files 8-K
SEC 8-K50 · neutralgeneral
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
StockTitan58 · neutralgeneral
Alto Neuroscience: Buy ALTO-207 Advancement TRD And Other Expansion Indications
Seeking Alpha67 · bullishanalyst
Alto Neuroscience, Inc. (ANRO) files 8-K
SEC 8-K50 · neutralgeneral
Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 Trials
TipRanks63 · neutralproduct/pr
Alto Neuroscience announces pricing of $100M underwritten registered direct offering of common stock
Seeking Alpha28 · bearishgeneral
Alto Neuroscience, Inc. (ANRO) files 8-K
SEC 8-K50 · neutralgeneral
Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment?
Yahoo Finance57 · neutralanalyst
Alto Neuroscience Appoints Andrew Miller to Board
TipRanks55 · neutralgeneral
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors | ANRO Stock News
StockTitan63 · neutralgeneral